SummaryCervical spondylotic myelopathy (CSM) is the leading cause of myelopathy in patients over age 50 years. Despite advances, CSM remains a clinical diagnosis and its natural history remains unclear. The treatment of CSM is controversial, especially in patients with mild or moderate clinical disease without rapid progression of symptoms. Herein, we begin with a clinical vignette followed by a brief description of the clinical problems. We discuss evaluation, treatment, and recommendations for the treatment of CSM. Emphasis is drawn to areas of uncertainty and present level of evidence for the treatment modalities of CSM.C ervical spondylotic myelopathy (CSM) is a degenerative condition of the cervical spine and the leading cause of myelopathy in those over the age of 50. 1-3 The exact incidence and prevalence of CSM is unknown. 1 Initially, patients may present with any of the following symptoms: neck pain and decreased mobility of the cervical spine, numb or clumsy hands, unsteady gait, hyperreflexia, and spasticity. In time, upper extremity weakness, muscle atrophy, or sphincter dysfunction might develop. [4][5][6][7] Clinical vignette A 61-year-old teacher with a history of intermittent neck pain is seen after 5 months of continuing neck pain. MRI 2 months after the onset of pain showed degenerative changes with spinal stenosis in the cervical region. He is very anxious because the first physician he consulted recommended decompressive surgery and the second recommended conservative treatment and to avoid surgery. He read on the Internet that he could eventually become paralyzed and therefore seeks further opinions. How should this patient be evaluated and treated?The pathophysiology of CSM involves 3 main components. The first component is the static factor, where structural changes cause spinal canal stenosis and cord compression. A strong correlation has been demonstrated between narrowing of the sagittal diameter of the cervical